Initial Workup for Hematuria
The initial workup for a patient presenting with hematuria should include a thorough history, physical examination, urinalysis with microscopic confirmation, and risk stratification to guide subsequent imaging and specialist referral. 1
Classification and Definition
Hematuria is classified into two main categories:
- Gross hematuria: Visible blood in urine (30-40% risk of malignancy)
- Microscopic hematuria: Defined as ≥3 red blood cells per high-power field on microscopic evaluation of urinary sediment from two of three properly collected specimens 1
Initial Evaluation Algorithm
Step 1: History and Risk Factor Assessment
Look specifically for:
Risk factors for urologic malignancy:
- Age >35 years
- Male gender
- Smoking history
- Occupational exposure to chemicals or dyes (benzenes, aromatic amines)
- History of gross hematuria
- Previous urologic disorder or disease
- Irritative voiding symptoms
- History of pelvic irradiation
- Chronic urinary tract infection
- Exposure to carcinogens or chemotherapy
- Chronic indwelling foreign body 1
Potential benign causes:
- Vigorous exercise
- Menstruation
- Sexual activity
- Trauma
- Recent urologic procedures
- Infection 1
Step 2: Urinalysis and Laboratory Testing
- Confirm hematuria with microscopic examination (dipstick alone has limited specificity of 65-99%) 1
- Urine culture to rule out infection
- Assess for glomerular source by checking for:
- Significant proteinuria (>1g/24hr)
- Red cell casts
- Dysmorphic red blood cells (requires phase contrast microscopy)
- Elevated serum creatinine 1
Step 3: Risk-Based Pathway Selection
Pathway A: If signs of renal parenchymal disease are present:
- Significant proteinuria
- Dysmorphic RBCs or RBC casts
- Elevated serum creatinine
- → Nephrology referral 1
Pathway B: If no signs of renal disease but urologic evaluation indicated:
- Gross hematuria (all cases)
- Microscopic hematuria with risk factors
- → Complete urologic workup 1
Urologic Evaluation Components
Imaging of the upper urinary tract:
Cystoscopy:
- Recommended for all patients with gross hematuria
- Recommended for patients >40 years with microscopic hematuria
- May be deferred in low-risk patients <40 years without risk factors 1
Urine cytology:
- Particularly useful for detecting high-grade tumors and carcinoma in situ 1
Special Considerations
- Gross hematuria: Requires urgent and complete evaluation due to high malignancy risk (30-40%) 1
- Anticoagulant therapy: Does not alter the need for urologic evaluation 1
- Persistent hematuria: Warrants continued surveillance even after initial negative evaluation 1
- Age consideration: Patients ≤40 years with microscopic hematuria and no risk factors may undergo less extensive initial evaluation 2
Follow-up Recommendations
For patients with negative initial evaluation:
- Repeat urinalysis, urine cytology, and blood pressure at 6,12,24, and 36 months
- Immediate re-evaluation if gross hematuria, abnormal cytology, or irritative voiding symptoms develop 1
Common Pitfalls to Avoid
- Relying solely on dipstick testing without microscopic confirmation
- Failing to evaluate for renal parenchymal disease when proteinuria or dysmorphic RBCs are present
- Assuming UTI as the cause without confirming with culture and follow-up urinalysis after treatment
- Neglecting follow-up in patients with persistent hematuria despite negative initial evaluation
- Underestimating the significance of gross hematuria, which requires urgent and complete evaluation regardless of age or risk factors
Remember that gross hematuria carries a significantly higher risk of malignancy and demands prompt, thorough evaluation in all cases.